Yale Cancer Center and Smilow Cancer Hospital Physicians and Scientists Presenting Latest Advances at 2023 ASCO Annual Meeting

Article

Press Release

In Partnership With:

Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology, June 2nd to June 6th at McCormick Place in Chicago, Illinois.

Eric Winer, MD

Eric Winer, MD

Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 2nd to June 6th at McCormick Place in Chicago, Illinois. This year’s scientific program will feature more than 2,900 abstracts, covering all major diseases and research areas, including breast, lung, head and neck, gynecological, prostate, and gastric cancers.

This year's meeting will include over 200 sessions, complementing Yale Cancer Center director and Smilow physician-in-chief, Dr Eric Winer's ASCO presidential theme, “Partnering With Patients: The Cornerstone of Cancer Care and Research.” Dr. Winer, the 2022-2023 ASCO President, will host the 2023 ASCO Meeting opening session and educational sessions in cancer research.

Some of the key presentations from Yale include:

Oral Abstract Session

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

IMerge: Results from a phase 3, randomized, double-blind, placebo-controlled study of imetelstat in patients (pts) with heavily transfusion dependent (TD) non-del(5q) lower-risk myelodysplastic syndromes (LR-MDS) relapsed/refractory (R/R) to erythropoiesi

Senior Author: Amer Zeidan, MBBS

June 2 —3:12 PM

Plenary Session

Special Sessions | Central Nervous System Tumors | Gastrointestinal Cancer—Colorectal and Anal | Lung Cancer | Hematologic Malignancies

Overall survival analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR‑mutated (EGFRm) stage IB–IIIA non-small cell lung cancer (NSCLC).

Presenter: Roy S. Herbst, MD, PhD

June 4 —3:17 PM

Plenary Session

Special Sessions | Central Nervous System Tumors | Gastrointestinal Cancer—Colorectal and Anal | Lung Cancer | Hematologic Malignancies

Panel Question and Answer

Moderator: Eric Winer, MD

June 4 — 3:17 PM

Abstract Discussion

Breast Cancer – Local/Regional/Adjuvant

Are We Splitting HERs? The Highs and Lows

Presenter: David Rimm, MD, PhD

June 4 —5:30 PM

Poster Session

Gynecologic Cancer

Racial and ethnic disparities in quality of diagnostic evaluation for uterine cancer among Medicare patients.

Speaker: Xiao Xu, PhD, MA

June 5 —2:15 PM

Poster Session

Care Delivery and Regulatory Policy

Trends in new and persistent opioid use in older adults with cancer.

Presenter: Henry Soo-Min Park, MD, MPH

June 5 — 2:15 PM

Oral Abstract Session

Breast Cancer—Metastatic

An age-specific pooled analysis of trastuzumab deruxtecan (T‑DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) from DESTINY-Breast01, -02, and -03.

Speaker: Ian Krop, MD, PhD

June 5 —2:30 PM

A full list of Yale Cancer Center and Smilow Cancer Hospital presenters at ASCO and schedule of events can be found here.

Related Videos
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
Martin H. Voss, MD, an expert on renal cell carcinoma
Laurence Albigès, MD, PhD, an expert on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma